Skip to Content

Notice

Importer of Controlled Substances Application: Sigma-Aldrich International GMBH

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007).

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix of subpart R.

In accordance with 21 CFR 1301.34(a), this is notice that on January 19, 2016, Sigma-Aldrich International GMBH, Sigma Aldrich Co. LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic classes of controlled substances:

Controlled substanceDrug codeSchedule
Cathinone1235I
Methcathinone1237I
Mephedrone (4-Methyl-N-methylcathinone)1248I
N-Ethylamphetamine1475I
Aminorex1585I
Gamma Hydroxybutyric Acid2010I
Start Printed Page 35548
Methaqualone2565I
Alpha-ethyltryptamine7249I
Ibogaine7260I
Lysergic acid diethylamide7315I
Marihuana7360I
Tetrahydrocannabinols7370I
Mescaline7381I
4-Bromo-2,5-dimethoxyamphetamine7391I
4-Bromo-2,5-dimethoxyphenethylamine7392I
4-Methyl-2,5-dimethoxyamphetamine7395I
2,5-Dimethoxyamphetamine7396I
3,4-Methylenedioxyamphetamine7400I
N-Hydroxy-3,4-methylenedioxyamphetamine7402I
3,4-Methylenedioxy-N-ethylamphetamine7404I
3,4-Methylenedioxymethamphetamine7405I
4-Methoxyamphetamine7411I
Bufotenine7433I
Diethyltryptamine7434I
Dimethyltryptamine7435I
Psilocybin7437I
Psilocyn7438I
1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
N-Benzylpiperazine7493I
MDPV (3,4-Methylenedioxypyrovalerone)7535I
Butylone7541I
Heroin9200I
Normorphine9313I
Etonitazene9624I
Amobarbital2125II
Pentobarbital2270II
Secobarbital2315II
Glutethimide2550II
Nabilone7379II
Phencyclidine7471II
Diphenoxylate9170II
Ecgonine9180II
Ethylmorphine9190II
Levorphanol9220II
Meperidine9230II
Thebaine9333II
Opium, powdered9639II
Levo-alphacetylmethadol9648II

The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis.

Start Signature

Dated: July 24, 2017.

Demetra Ashley,

Acting Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2017-16059 Filed 7-28-17; 8:45 am]

BILLING CODE 4410-09-P